+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asia Pacific Rapid Diagnostics Market 2021-2031 by Product, Prescription, Platform, Application, End User, and Country: Trend Forecast and Growth Opportunity

  • PDF Icon

    Report

  • 126 Pages
  • December 2022
  • Region: Asia Pacific
  • GMD Research
  • ID: 5712793

Asia Pacific Rapid Diagnostics will grow by 10.9% annually with a total addressable market cap of $ 129,373.7 million over 2022-2031, driven by the growing demand for POC diagnostics, the rising prevalence of chronic diseases coupled with the increasing aging population, the growing necessity for rapid decision making in emergency departments, increase in awareness regarding early diagnosis of disease, and emerging technological innovations.

Highlighted with 35 tables and 64 figures, this 126-page report “Asia Pacific Rapid Diagnostics Market 2021-2031 by Product (Consumables, Analyzers/Instruments), Prescription (Professional, OTC), Platform (Immunoassays, Molecular Detection, Others), Application, End User, and Country: Trend Forecast and Growth Opportunity” is based on comprehensive research of the entire Asia Pacific Rapid Diagnostics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

  • Market Structure
  • Growth Drivers
  • Restraints and Challenges
  • Emerging Product Trends & Market Opportunities
  • Porter’s Fiver Forces

The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Asia Pacific Rapid Diagnostics market in every aspect of the classification from perspectives of Product, Prescription, Platform, Application, End User, and Country.

Based on Product, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

  • Consumables
  • Analyzers/Instruments

Based on Prescription, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

  • Professional Diagnostics
  • OTC Based Testing

By Platform, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

Immunoassays

  • Lateral Flow Assays
  • Serological Assays
  • Other Immunoassays

Molecular Detection

  • Polymerase Chain Reaction (PCR)
  • Other Molecular Detection Tests
  • Other Platforms

By Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

  • Blood Glucose Testing
  • Cardiometabolic Testing
  • Infectious Disease Testing
  • COVID-19 Testing
  • Healthcare-associated Infections (HAI) Testing
  • Hepatitis Testing
  • Tropical Diseases Testing
  • HIV Testing
  • Influenza Testing
  • Sexually Transmitted Diseases (STD) Testing
  • Other Infectious Diseases Testing
  • Blood Coagulation Testing
  • Hematology Testing
  • Cancer Testing
  • Drug Abuse Testing
  • Pregnancy & Fertility Testing
  • Other Applications

By End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

  • Hospitals & Clinics
  • Laboratories
  • Individuals/Homecare
  • Other End Users

Geographically, the following national/local markets are fully investigated:

  • Japan
  • China
  • South Korea
  • Australia
  • India
  • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)

For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Product, Prescription and Application over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:

  • Abbott Diagnostics
  • ACON Laboratories
  • Becton Dickinson and Co.
  • BioMérieux S.A.
  • Bio-Rad Laboratories, Inc.
  • Chembio Diagnostic Systems
  • Danaher Corp.
  • F. Hoffmann La Roche Ltd.
  • GlySens Inc.
  • Meridian Bioscience Inc.
  • OraSure Technologies Inc.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Trinity Biotech Plc

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Frequently Asked Questions about the Asian Pacific Rapid Diagnostics Market

What is the estimated value of the Asian Pacific Rapid Diagnostics Market?

The Asian Pacific Rapid Diagnostics Market was estimated to be valued at $7286.9 Million in 2021.

What is the growth rate of the Asian Pacific Rapid Diagnostics Market?

The growth rate of the Asian Pacific Rapid Diagnostics Market is 10.9%, with an estimated value of $20576.8 Million by 2031.

What is the forecasted size of the Asian Pacific Rapid Diagnostics Market?

The Asian Pacific Rapid Diagnostics Market is estimated to be worth $20576.8 Million by 2031.

Who are the key companies in the Asian Pacific Rapid Diagnostics Market?

Key companies in the Asian Pacific Rapid Diagnostics Market include Abbott Diagnostics, ACON Laboratories, Becton Dickinson and Co., BioMérieux S.A., Bio, Rad Laboratories, Inc., Chembio Diagnostic Systems, Danaher Corp. and GlySens Inc..

Table of Contents

1 Introduction
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary
2 Market Overview and Dynamics
2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on World Economy
2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis
3 Segmentation of Asia Pacific Market by Product
3.1 Market Overview by Product
3.2 Consumables
3.3 Analyzers/Instruments
4 Segmentation of Asia Pacific Market by Prescription
4.1 Market Overview by Prescription
4.2 Professional Diagnostics
4.3 OTC Based Testing
5 Segmentation of Asia Pacific Market by Platform
5.1 Market Overview by Platform
5.2 Immunoassays
5.2.1 Lateral Flow Assays
5.2.2 Serological Assays
5.2.3 Other Immunoassays
5.3 Molecular Detection
5.3.1 Polymerase Chain Reaction (PCR)
5.3.2 Other Molecular Detection Tests
5.4 Other Platforms
6 Segmentation of Asia Pacific Market by Application
6.1 Market Overview by Application
6.2 Blood Glucose Testing
6.3 Cardiometabolic Testing
6.4 Infectious Disease Testing
6.4.1 COVID-19 Testing
6.4.2 Healthcare-associated Infections (HAI) Testing
6.4.3 Hepatitis Testing
6.4.4 Tropical Diseases Testing
6.4.5 HIV Testing
6.4.6 Influenza Testing
6.4.7 Sexually Transmitted Diseases (STD) Testing
6.4.8 Other Infectious Diseases Testing
6.5 Blood Coagulation Testing
6.6 Hematology Testing
6.7 Cancer Testing
6.8 Drug Abuse Testing
6.9 Pregnancy & Fertility Testing
6.10 Other Applications
7 Segmentation of Asia Pacific Market by End User
7.1 Market Overview by End User
7.2 Hospitals & Clinics
7.3 Laboratories
7.4 Individuals/Homecare
7.5 Other End Users
8 Asia-Pacific Market 2021-2031 by Country
8.1 Overview of Asia-Pacific Market
8.2 Japan
8.3 China
8.4 Australia
8.5 India
8.6 South Korea
8.7 Rest of APAC Region
9 Competitive Landscape
9.1 Overview of Key Vendors
9.2 New Product Launch, Partnership, Investment, and M&A
9.3 Company Profiles
  • Abbott Diagnostics
  • ACON Laboratories
  • Becton Dickinson and Co.
  • BioMérieux S.A.
  • Bio-Rad Laboratories, Inc.
  • Chembio Diagnostic Systems
  • Danaher Corp.
  • F. Hoffmann La Roche Ltd.
  • GlySens Inc.
  • Meridian Bioscience Inc.
  • OraSure Technologies Inc.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Trinity Biotech Plc
List of Tables
Table 1. Snapshot of Asia Pacific Rapid Diagnostics Market in Balanced Perspective, 2021-2031
Table 2. World Economic Outlook, 2021-2031
Table 3. World Economic Outlook, 2021-2023
Table 4. World Health Spending by Region, $ bn, 2013-2020
Table 5. Main Product Trends and Market Opportunities in Asia Pacific Rapid Diagnostics Market
Table 6. Asia Pacific Rapid Diagnostics Market by Product, 2021-2031, $ mn
Table 7. Asia Pacific Rapid Diagnostics Market by Prescription, 2021-2031, $ mn
Table 8. Asia Pacific Rapid Diagnostics Market by Platform, 2021-2031, $ mn
Table 9. Asia Pacific Rapid Diagnostics Market: Immunoassays by Type, 2021-2031, $ mn
Table 10. Asia Pacific Rapid Diagnostics Market: Molecular Detection by Type, 2021-2031, $ mn
Table 11. Asia Pacific Rapid Diagnostics Market by Application, 2021-2031, $ mn
Table 12. Asia Pacific Rapid Diagnostics Market: Infectious Disease Testing by Type, 2021-2031, $ mn
Table 13. Asia Pacific Rapid Diagnostics Market by End User, 2021-2031, $ mn
Table 14. APAC Rapid Diagnostics Market by Country, 2021-2031, $ mn
Table 15. Japan Rapid Diagnostics Market by Product, 2021-2031, $ mn
Table 16. Japan Rapid Diagnostics Market by Prescription, 2021-2031, $ mn
Table 17. Japan Rapid Diagnostics Market by Application, 2021-2031, $ mn
Table 18. China Rapid Diagnostics Market by Product, 2021-2031, $ mn
Table 19. China Rapid Diagnostics Market by Prescription, 2021-2031, $ mn
Table 20. China Rapid Diagnostics Market by Application, 2021-2031, $ mn
Table 21. Australia Rapid Diagnostics Market by Product, 2021-2031, $ mn
Table 22. Australia Rapid Diagnostics Market by Prescription, 2021-2031, $ mn
Table 23. Australia Rapid Diagnostics Market by Application, 2021-2031, $ mn
Table 24. India Rapid Diagnostics Market by Product, 2021-2031, $ mn
Table 25. India Rapid Diagnostics Market by Prescription, 2021-2031, $ mn
Table 26. India Rapid Diagnostics Market by Application, 2021-2031, $ mn
Table 27. South Korea Rapid Diagnostics Market by Product, 2021-2031, $ mn
Table 28. South Korea Rapid Diagnostics Market by Prescription, 2021-2031, $ mn
Table 29. South Korea Rapid Diagnostics Market by Application, 2021-2031, $ mn
Table 30. Rapid Diagnostics Market in Rest of APAC by Country/Region, 2021-2031, $ mn
Table 31. Rapid Diagnostic Analyzers by Vendor
Table 32. Recent Product Launches, 2018-2021
Table 33. Abbott Diagnostics: Company Snapshot
Table 34. Abbott Diagnostics: Business Segmentation
Table 35. Abbott Diagnostics: Product Portfolio
List of Figures
Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031
Figure 4. Asia Pacific Rapid Diagnostics Market, 2021-2031, $ mn
Figure 5. Impact of COVID-19 on Business
Figure 6. Primary Drivers and Impact Factors of Asia Pacific Rapid Diagnostics Market
Figure 7. Leading Causes of Death in the World, 2000 and 2019, million
Figure 8. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million
Figure 9. World Population 65 and Over, % of Total Population, 1950-2060
Figure 10. Primary Restraints and Impact Factors of Asia Pacific Rapid Diagnostics Market
Figure 11. Investment Opportunity Analysis
Figure 12. Porter’s Fiver Forces Analysis of Asia Pacific Rapid Diagnostics Market
Figure 13. Breakdown of Asia Pacific Rapid Diagnostics Market by Product, 2021-2031, % of Revenue
Figure 14. Asia Pacific Addressable Market Cap in 2022-2031 by Product, Value ($ mn) and Share (%)
Figure 15. Asia Pacific Rapid Diagnostics Market by Product: Consumables, 2021-2031, $ mn
Figure 16. Asia Pacific Rapid Diagnostics Market by Product: Analyzers/Instruments, 2021-2031, $ mn
Figure 17. Breakdown of Asia Pacific Rapid Diagnostics Market by Prescription, 2021-2031, % of Sales Revenue
Figure 18. Asia Pacific Addressable Market Cap in 2022-2031 by Prescription, Value ($ mn) and Share (%)
Figure 19. Asia Pacific Rapid Diagnostics Market by Prescription: Professional Diagnostics, 2021-2031, $ mn
Figure 20. Asia Pacific Rapid Diagnostics Market by Prescription: OTC Based Testing, 2021-2031, $ mn
Figure 21. Breakdown of Asia Pacific Rapid Diagnostics Market by Platform, 2021-2031, % of Sales Revenue
Figure 22. Asia Pacific Addressable Market Cap in 2022-2031 by Platform, Value ($ mn) and Share (%)
Figure 23. Asia Pacific Rapid Diagnostics Market by Platform: Immunoassays, 2021-2031, $ mn
Figure 24. Asia Pacific Rapid Diagnostics Market by Immunoassays: Lateral Flow Assays, 2021-2031, $ mn
Figure 25. Asia Pacific Rapid Diagnostics Market by Immunoassays: Serological Assays, 2021-2031, $ mn
Figure 26. Asia Pacific Rapid Diagnostics Market by Immunoassays: Other Immunoassays, 2021-2031, $ mn
Figure 27. Asia Pacific Rapid Diagnostics Market by Platform: Molecular Detection, 2021-2031, $ mn
Figure 28. Asia Pacific Rapid Diagnostics Market by Molecular Detection: Polymerase Chain Reaction (PCR), 2021-2031, $ mn
Figure 29. Asia Pacific Rapid Diagnostics Market by Molecular Detection: Other Molecular Detection Tests, 2021-2031, $ mn
Figure 30. Asia Pacific Rapid Diagnostics Market by Platform: Other Platforms, 2021-2031, $ mn
Figure 31. Breakdown of Asia Pacific Rapid Diagnostics Market by Application, 2021-2031, % of Revenue
Figure 32. Asia Pacific Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%)
Figure 33. Asia Pacific Rapid Diagnostics Market by Application: Blood Glucose Testing, 2021-2031, $ mn
Figure 34. Asia Pacific Rapid Diagnostics Market by Application: Cardiometabolic Testing, 2021-2031, $ mn
Figure 35. Asia Pacific Rapid Diagnostics Market by Application: Infectious Disease Testing, 2021-2031, $ mn
Figure 36. Asia Pacific Rapid Diagnostics Market by Infectious Disease Testing: COVID-19 Testing, 2021-2031, $ mn
Figure 37. Asia Pacific Rapid Diagnostics Market by Infectious Disease Testing: Healthcare-associated Infections (HAI) Testing, 2021-2031, $ mn
Figure 38. Asia Pacific Rapid Diagnostics Market by Infectious Disease Testing: Hepatitis Testing, 2021-2031, $ mn
Figure 39. Asia Pacific Rapid Diagnostics Market by Infectious Disease Testing: Tropical Diseases Testing, 2021-2031, $ mn
Figure 40. Asia Pacific Rapid Diagnostics Market by Infectious Disease Testing: HIV Testing, 2021-2031, $ mn
Figure 41. Asia Pacific Rapid Diagnostics Market by Infectious Disease Testing: Influenza Testing, 2021-2031, $ mn
Figure 42. Asia Pacific Rapid Diagnostics Market by Infectious Disease Testing: Sexually Transmitted Diseases (STD) Testing, 2021-2031, $ mn
Figure 43. Asia Pacific Rapid Diagnostics Market by Infectious Disease Testing: Other Infectious Diseases Testing, 2021-2031, $ mn
Figure 44. Asia Pacific Rapid Diagnostics Market by Application: Blood Coagulation Testing, 2021-2031, $ mn
Figure 45. Asia Pacific Rapid Diagnostics Market by Application: Hematology Testing, 2021-2031, $ mn
Figure 46. Asia Pacific Rapid Diagnostics Market by Application: Cancer Testing, 2021-2031, $ mn
Figure 47. Asia Pacific Rapid Diagnostics Market by Application: Drug Abuse Testing, 2021-2031, $ mn
Figure 48. Asia Pacific Rapid Diagnostics Market by Application: Pregnancy & Fertility Testing, 2021-2031, $ mn
Figure 49. Asia Pacific Rapid Diagnostics Market by Application: Other Applications, 2021-2031, $ mn
Figure 50. Breakdown of Asia Pacific Rapid Diagnostics Market by End User, 2021-2031, % of Revenue
Figure 51. Asia Pacific Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%)
Figure 52. Asia Pacific Rapid Diagnostics Market by End User: Hospitals & Clinics, 2021-2031, $ mn
Figure 53. Asia Pacific Rapid Diagnostics Market by End User: Laboratories, 2021-2031, $ mn
Figure 54. Asia Pacific Rapid Diagnostics Market by End User: Individuals/Homecare, 2021-2031, $ mn
Figure 55. Asia Pacific Rapid Diagnostics Market by End User: Other End Users, 2021-2031, $ mn
Figure 56. Breakdown of APAC Rapid Diagnostics Market by Country, 2021 and 2031, % of Revenue
Figure 57. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 58. Rapid Diagnostics Market in Japan, 2021-2031, $ mn
Figure 59. Rapid Diagnostics Market in China, 2021-2031, $ mn
Figure 60. Rapid Diagnostics Market in Australia, 2021-2031, $ mn
Figure 61. Rapid Diagnostics Market in India, 2021-2031, $ mn
Figure 62. Rapid Diagnostics Market in South Korea, 2021-2031, $ mn
Figure 63. Rapid Diagnostics Market in Rest of APAC, 2021-2031, $ mn
Figure 64. Growth Stage of Asia Pacific Rapid Diagnostics Industry over the Forecast Period

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott Diagnostics
  • ACON Laboratories
  • Becton Dickinson and Co.
  • BioMérieux S.A.
  • Bio-Rad Laboratories, Inc.
  • Chembio Diagnostic Systems
  • Danaher Corp.
  • F. Hoffmann La Roche Ltd.
  • GlySens Inc.
  • Meridian Bioscience Inc.
  • OraSure Technologies Inc.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Trinity Biotech Plc

Methodology

Loading
LOADING...